EA200601575A1 - Казеиновые пептиды и их терапевтическое применение - Google Patents
Казеиновые пептиды и их терапевтическое применениеInfo
- Publication number
- EA200601575A1 EA200601575A1 EA200601575A EA200601575A EA200601575A1 EA 200601575 A1 EA200601575 A1 EA 200601575A1 EA 200601575 A EA200601575 A EA 200601575A EA 200601575 A EA200601575 A EA 200601575A EA 200601575 A1 EA200601575 A1 EA 200601575A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- peptides
- casein
- stimulation
- therapeutic application
- casein peptides
- Prior art date
Links
- 239000005018 casein Substances 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 3
- 235000021240 caseins Nutrition 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000011632 Caseins Human genes 0.000 abstract 2
- 108010076119 Caseins Proteins 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 2
- 208000014951 hematologic disease Diseases 0.000 abstract 2
- 230000000638 stimulation Effects 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000011132 hemopoiesis Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000010606 normalization Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54840104P | 2004-03-01 | 2004-03-01 | |
| PCT/IL2005/000211 WO2005081628A2 (en) | 2004-03-01 | 2005-02-20 | Casein derived peptides and therapeutic uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200601575A1 true EA200601575A1 (ru) | 2007-06-29 |
Family
ID=34910999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200601575A EA200601575A1 (ru) | 2004-03-01 | 2005-02-20 | Казеиновые пептиды и их терапевтическое применение |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070203060A1 (enExample) |
| EP (1) | EP1751179A4 (enExample) |
| JP (1) | JP2008509073A (enExample) |
| KR (1) | KR20070007128A (enExample) |
| CN (1) | CN101124261A (enExample) |
| AU (1) | AU2005215943A1 (enExample) |
| BR (1) | BRPI0507822A (enExample) |
| CA (1) | CA2558155A1 (enExample) |
| EA (1) | EA200601575A1 (enExample) |
| MX (1) | MXPA06010014A (enExample) |
| NO (1) | NO20064388L (enExample) |
| WO (1) | WO2005081628A2 (enExample) |
| ZA (1) | ZA200607735B (enExample) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1956994B (zh) * | 2004-03-31 | 2012-09-05 | 特许技术开发株式会社 | 上皮系细胞增殖促进剂 |
| JP5068174B2 (ja) * | 2004-12-23 | 2012-11-07 | カンピナ ネーデルランド ホールディング ビー．ブイ． | Ｄｐｐ−ｉｖを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用 |
| NZ560601A (en) * | 2005-02-24 | 2009-09-25 | Dsm Ip Assets Bv | Process to produce IPP tripeptide from glycomacropeptide using proline specific proteolytic enzyme |
| EA016039B1 (ru) | 2005-05-02 | 2012-01-30 | Милеутис Лтд. | Способы ухода за лактирующими животными и фармацевтические композиции, используемые для их осуществления |
| CA2625183C (en) | 2005-10-04 | 2019-09-03 | Inimex Pharmaceuticals Inc. | Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| JP2009516738A (ja) * | 2005-11-21 | 2009-04-23 | ティーガスク−ザ アグリカルチャー アンド フード デベロップメント オーソリティー | カゼイン由来の抗菌ペプチドおよびそれを生成するＬａｃｔｏｂａｃｉｌｌｕｓ株 |
| JP2009517464A (ja) * | 2005-11-30 | 2009-04-30 | カンピーナ ネーダーランド ホールディング ビー．ブイ． | グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用 |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| DK1994155T4 (da) | 2006-02-13 | 2022-07-25 | Daiichi Sankyo Co Ltd | Polynukleotid- og polypeptidsekvenser involveret i fremgangsmåden med knogleremodellering |
| JP2007254449A (ja) * | 2006-02-22 | 2007-10-04 | Snow Brand Milk Prod Co Ltd | 脂質改善剤 |
| JP5177778B2 (ja) * | 2006-02-24 | 2013-04-10 | 雪印メグミルク株式会社 | ペプチド |
| GB2436328A (en) * | 2006-03-22 | 2007-09-26 | Regen Therapeutics Plc | Peptide derived from colostrinin |
| RU2008144426A (ru) * | 2006-04-11 | 2010-05-20 | Милеутис Лтд. (Il) | Регулирование репродуктивной эффективности сельскохозяйственных животных |
| EP2017283A4 (en) * | 2006-04-28 | 2015-12-30 | Megmilk Snow Brand Co Ltd | Peptides |
| EP3231442B1 (en) | 2006-06-23 | 2019-12-25 | ADC Therapeutics SA | Polynucleotides and polypeptide sequences involved in cancer |
| JP5188731B2 (ja) * | 2007-03-02 | 2013-04-24 | 雪印メグミルク株式会社 | ペプチド |
| WO2009138762A2 (en) * | 2008-05-15 | 2009-11-19 | Regen Therapeutics Plc | Therapeutic use of peptides |
| NZ571856A (en) * | 2008-10-09 | 2011-02-25 | Fonterra Corporate Res And Dev Ltd | Use of a phospholipid and ganglioside composition for the treatment or prevention of gout |
| WO2010060186A1 (en) | 2008-11-03 | 2010-06-03 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| EP2370088B1 (en) | 2008-12-27 | 2016-08-24 | Pawan Saharan | Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| RU2011144581A (ru) | 2009-04-03 | 2013-05-10 | Нестек С.А. | Улучшение стимулирования здоровья при "догоняющем росте" |
| US20110104179A1 (en) * | 2009-06-19 | 2011-05-05 | Oral Health Australia Pty Ltd | Protease inhibitory peptides |
| WO2011050471A1 (en) * | 2009-10-28 | 2011-05-05 | University Of Manitoba | Yellow pea seed protein-derived peptides |
| JP5479884B2 (ja) * | 2009-12-28 | 2014-04-23 | カルピス株式会社 | 脳機能改善用組成物および脳機能を改善する方法 |
| EP2560669B2 (en) * | 2010-04-21 | 2017-10-04 | Mileutis Ltd. | Casein peptide for use in the treatment of uterine infections |
| PT105073A (pt) * | 2010-04-26 | 2011-10-26 | Consejo Superior Investigacion | Processo de obtenção de extractos peptídicos bioactivos através da hidrólise de proteínas de soro de leite com enzimas de cynara cardunculus, referidos extractos e respectivas utilizações |
| PL3173427T3 (pl) | 2011-03-31 | 2019-11-29 | Adc Therapeutics Sa | Przeciwciała przeciwko antygenowi związanemu z nerkami 1 i ich fragmenty wiążące antygen |
| US8865155B2 (en) * | 2011-09-29 | 2014-10-21 | Centro De Investigacion En Alimentacion Y Desarrollo, A.C. (Ciad) | Lactococcus lactis strains, and bacterial preparations thereof, for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects in mammals; nutritional and therapeutic products produced therefrom |
| AU2013209234B2 (en) | 2012-01-09 | 2017-11-09 | Adc Therapeutics Sa | Method for treating breast cancer |
| JP5976004B2 (ja) * | 2012-03-09 | 2016-08-23 | 森永乳業株式会社 | ジペプチジルペプチダーゼ−ｉｖ阻害剤 |
| US9493562B2 (en) | 2012-07-19 | 2016-11-15 | Alethia Biotherapeutics Inc. | Anti-Siglec-15 antibodies |
| CN102964427B (zh) * | 2012-12-12 | 2014-01-15 | 上海交通大学 | 一种生物活性多肽qepvl及其制备和应用 |
| CN103012552B (zh) * | 2012-12-12 | 2014-03-12 | 上海交通大学 | 一种生物活性多肽qepv及其制备和应用 |
| US10251928B2 (en) * | 2014-11-06 | 2019-04-09 | Mead Johnson Nutrition Company | Nutritional supplements containing a peptide component and uses thereof |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345727B2 (en) * | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9352020B2 (en) * | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US11215615B2 (en) * | 2014-04-03 | 2022-01-04 | AllerGenis LLC | Peptides, reagents and methods for detecting food allergy |
| CN104697830B (zh) * | 2015-02-10 | 2018-06-15 | 深圳市新产业生物医学工程股份有限公司 | 用于hiv检测的酸性处理剂、样本预处理方法、试剂盒及检测方法 |
| WO2016208641A1 (ja) * | 2015-06-22 | 2016-12-29 | 株式会社明治 | 血中ヘモグロビン増加用組成物 |
| AU2018227125A1 (en) * | 2017-03-03 | 2019-10-24 | Morinaga Milk Industry Co., Ltd. | GLP-1 secretagogue and composition |
| CN107176995B (zh) * | 2017-07-06 | 2019-12-24 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽skvlpvpekavpypq及其制备方法和应用 |
| CN107188949B (zh) * | 2017-07-06 | 2019-12-24 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽eintvqvtst及其制备方法和应用 |
| AU2018332486B2 (en) * | 2017-09-15 | 2022-06-02 | Kine Sciences Co., Ltd. | Use of peptides as therapeutic agent for autoimmune diseases and bone diseases |
| CN107903314A (zh) * | 2017-11-14 | 2018-04-13 | 上海交通大学 | 一种生物活性多肽eviesppeintv及其制备方法和应用 |
| TWI655203B (zh) * | 2017-11-16 | 2019-04-01 | 國立中興大學 | 新穎胜肽、含有該胜肽之組合物及其用途 |
| CN107814835B (zh) * | 2017-12-01 | 2020-04-28 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽avpitptlnreq及其制备方法和应用 |
| CN107880102A (zh) * | 2017-12-07 | 2018-04-06 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽peviesppein及其制备方法和应用 |
| CN107827971B (zh) * | 2017-12-07 | 2020-04-14 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽qsltltdve及其制备方法和应用 |
| CN107759682B (zh) * | 2017-12-07 | 2021-03-02 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽pigsensgkttmpl及其制备方法和应用 |
| CN107814839A (zh) * | 2017-12-07 | 2018-03-20 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽pigsensekttmpl及其制备方法和应用 |
| CN107880106B (zh) * | 2017-12-11 | 2020-06-16 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽vpitptlnre及其制备方法和应用 |
| CN107880104A (zh) * | 2017-12-11 | 2018-04-06 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽sppeintvqvt及其制备方法和应用 |
| CN107880105B (zh) * | 2017-12-11 | 2020-06-16 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽vpitptlnr及其制备方法和应用 |
| CN108017703B (zh) * | 2017-12-11 | 2020-07-17 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽vpitptln及其制备方法和应用 |
| CN107827972A (zh) * | 2017-12-11 | 2018-03-23 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽speviesppein及其制备方法和应用 |
| CN107880108A (zh) * | 2017-12-12 | 2018-04-06 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽sfsdipnpigse及其制备方法和应用 |
| CN108017708A (zh) * | 2017-12-12 | 2018-05-11 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽npigsensekttmpl及其制备方法和应用 |
| CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
| CN108034002A (zh) * | 2017-12-12 | 2018-05-15 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽peviesppeintv及其制备方法和应用 |
| CN107814840B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽pkypvepf及其制备方法和应用 |
| KR102073824B1 (ko) * | 2018-04-11 | 2020-02-05 | 강원대학교산학협력단 | 간 보호용 건강기능식품 및 이의 제조 방법 |
| EP4363435A4 (en) * | 2021-06-29 | 2025-06-04 | Gill, Thomas A. | PEPTIDES FOR REGULATION OF GLUCOSE |
| CN113952446B (zh) * | 2021-09-03 | 2023-12-05 | 河南省医药科学研究院 | 生物活性肽在抑制骨髓毒性中的应用 |
| CN115724982B (zh) * | 2022-08-12 | 2023-07-04 | 广西壮族自治区水牛研究所 | 一种用于检测水牛奶中掺假普通牛乳的单克隆抗体及其制备方法和用途 |
| NL2033588B1 (en) * | 2022-11-22 | 2024-05-30 | Univ Ningbo | Duck liver protein-derived anti-inflammatory and antimicrobial functional peptide and preparation method and application thereof |
| CN119320440A (zh) * | 2023-07-06 | 2025-01-17 | 中国科学院大连化学物理研究所 | 一种抗菌肽及其应用 |
| CN117567586A (zh) * | 2023-10-25 | 2024-02-20 | 广州菲勒生物科技有限公司 | 一种富含唾液酸化肽的水解酪蛋白的制备方法及其在调节肠道菌群中的应用 |
| CN118452475A (zh) * | 2024-04-10 | 2024-08-09 | 江南大学 | 一种促钙吸收后生元的制备方法及其应用 |
| CN119119181A (zh) * | 2024-09-24 | 2024-12-13 | 西北农林科技大学 | 一种cox2抑制肽、抑制cox2的组合物与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968901A (en) * | 1989-10-30 | 1999-10-19 | Andersson; Bengt | Antibacterial composition |
| US5707968A (en) * | 1994-05-26 | 1998-01-13 | Abbott Laboratories | Inhibition of attachment of H.influenzae to human cells |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| TWI268138B (en) * | 2000-05-11 | 2006-12-11 | Kanebo Seiyaku Ltd | Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same |
| JP2005511499A (ja) * | 2001-08-30 | 2005-04-28 | チャイ １３ メディカル リサーチ グループ エヌ． ヴイ． | カゼイン由来ペプチドおよびその医療用途 |
-
2005
- 2005-02-20 EA EA200601575A patent/EA200601575A1/ru unknown
- 2005-02-20 CA CA002558155A patent/CA2558155A1/en not_active Abandoned
- 2005-02-20 BR BRPI0507822-9A patent/BRPI0507822A/pt not_active IP Right Cessation
- 2005-02-20 EP EP05709111A patent/EP1751179A4/en not_active Withdrawn
- 2005-02-20 US US10/591,405 patent/US20070203060A1/en not_active Abandoned
- 2005-02-20 AU AU2005215943A patent/AU2005215943A1/en not_active Abandoned
- 2005-02-20 MX MXPA06010014A patent/MXPA06010014A/es not_active Application Discontinuation
- 2005-02-20 JP JP2007501441A patent/JP2008509073A/ja active Pending
- 2005-02-20 WO PCT/IL2005/000211 patent/WO2005081628A2/en not_active Ceased
- 2005-02-20 KR KR1020067020558A patent/KR20070007128A/ko not_active Withdrawn
- 2005-02-20 CN CNA2005800140129A patent/CN101124261A/zh active Pending
-
2006
- 2006-09-15 ZA ZA200607735A patent/ZA200607735B/en unknown
- 2006-09-28 NO NO20064388A patent/NO20064388L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070203060A1 (en) | 2007-08-30 |
| EP1751179A2 (en) | 2007-02-14 |
| JP2008509073A (ja) | 2008-03-27 |
| CA2558155A1 (en) | 2005-09-09 |
| EP1751179A4 (en) | 2009-03-25 |
| BRPI0507822A (pt) | 2007-07-10 |
| WO2005081628A3 (en) | 2007-10-18 |
| MXPA06010014A (es) | 2007-03-07 |
| CN101124261A (zh) | 2008-02-13 |
| WO2005081628A2 (en) | 2005-09-09 |
| NO20064388L (no) | 2006-11-28 |
| KR20070007128A (ko) | 2007-01-12 |
| AU2005215943A1 (en) | 2005-09-09 |
| ZA200607735B (en) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200601575A1 (ru) | Казеиновые пептиды и их терапевтическое применение | |
| KR20030025907A (ko) | 카세인 유도 펩타이드 및 이들의 치료 용도 | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE475423T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen | |
| EA200801570A1 (ru) | Стабильные белковые препараты | |
| ATE314095T1 (de) | Virusähnliche partikel zur induktion von autoantikörpern | |
| ATE531382T1 (de) | Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen | |
| CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| MX2021008207A (es) | Proteínas de fusión multifuncionales y usos de las mismas. | |
| EA200000911A1 (ru) | Новые кристаллические формы антивирусного соединения бензимидазола | |
| EA200700886A1 (ru) | Соединение тиадиазола и его применение | |
| BRPI0813699A2 (pt) | Formulações de proteína de fusão glp-1-fc | |
| ATE516366T1 (de) | Regulierte aptamer-therapeutika | |
| EP4225382A4 (en) | ADMINISTRATION OF THERAPEUTIC ADENO-ASSOCIATED VIRUS FUKKUTIN-ASSOCIATED PROTEIN (FKRP) FOR THE TREATMENT OF DYSTROGLYCANOPATHY. DISORDERS INCLUDING LIMB GIRDLE 21 | |
| KR20040078639A (ko) | 카세인 유도 펩타이드 및 이들의 치료 용도 | |
| ATE460431T1 (de) | Nicht-neutralisierende anti-apc-antikörper | |
| WO2004026260A3 (en) | Prophylactic and therapeutic hiv aptamers | |
| UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
| MA29625B1 (fr) | Immunoglobulines | |
| ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| BRPI0510659A (pt) | indução de uma resposta imunológica contra polissacarìdeos de streptococcus pneumoniae | |
| EA200600314A1 (ru) | Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях | |
| ATE544453T1 (de) | Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen | |
| ATE495750T1 (de) | Sulfatide zur behandlung von autoimmunkrankheiten | |
| WO2020112847A3 (en) | Immune supplement composition |